EZZ Life Science Holdings Limited
EZZ
Rank in Stocks
#28676
EZZ Life Science Holdings Limited, an Australian company, specializes in... EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
Share Price
$0.21013046
Last synced: 2026-11-16
Market Cap
$9.89M
Change (1 day)
4.67%
Change (1 year)
-86.63%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade EZZ Life Science Holdings Limited (EZZ)
Category
Healthcare
EPS for EZZ Life Science Holdings Limited (EZZ)
EPS as of June 2026 TTM: $-0.07
According to EZZ Life Science Holdings Limited's latest financial reports, its current EPS (TTM) is $-0.07. At the end of 2025 the company had an EPS of $0.10, a decrease compared to its 2024 EPS of $0.11.
EPS history for EZZ Life Science Holdings Limited from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.07 | -174.50% |
| 2025 | $0.10 | -7.58% |
| 2024 | $0.11 | 88.69% |
| 2023 | $0.06 | 165.73% |
| 2022 | $0.02 | -41.16% |
| 2021 | $0.04 | 38.70% |
| 2020 | $0.03 | 89.13% |
| 2019 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 1,094.63% |
US
|
|
| $15.66 | -21,120.13% |
US
|
|
| $-7.07 | 9,389.93% |
US
|
|
| $-5.29 | 7,000.67% |
AU
|
|
| $12.73 | -17,190.20% |
BE
|
Questions about EZZ Life Science Holdings Limited's earnings per share (EPS)
What is EZZ Life Science Holdings Limited's earnings per share (EPS)?
EZZ Life Science Holdings Limited's earnings per share (EPS) over the last twelve months is $-0.07, as of Jun 2026.
What was EZZ Life Science Holdings Limited's earnings per share (EPS) in 2025?
In 2025, EZZ Life Science Holdings Limited's earnings per share (EPS) was $0.10, 9.09% less than in 2024 ($0.11).
How has EZZ Life Science Holdings Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, EZZ Life Science Holdings Limited's earnings per share (EPS) went from $0.03 to $0.10, an average growth of 27.23% a year.
How does EZZ Life Science Holdings Limited's earnings per share (EPS) compare with similar companies?
EZZ Life Science Holdings Limited's earnings per share (EPS) ($-0.07) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.